Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-NMI Antibody (R1B09)

Catalog #:   RHG47301 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IHC, IP, WB
Accession: Q13287
Overview

Catalog No.

RHG47301

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IHC: 1:100-1:200, IP: 1:20-1:50, WB: 1:1000-1:2000

Target

N myc interactor, NMI, NMYC and STAT interactor, NMYC interactor, N myc interactor

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q13287

Applications

IF, IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4 ℃ short term (1-2 weeks). Store at -20 ℃ 12 months. Store at -80 ℃ long term.

Clone ID

R1B09

Data Image
  • Immunoprecipitation
    Immunoprecipitate (IP) analysis using the Antibody at 1:50 dilution. (wb at 1:1K dilution)
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
  • Western blot
    Western blot analysis of NMI expression in HeLa cell lysate.
References

Lossless single-molecule counting to absolute quantify proteoforms., PMID:40025113

Mass spectrometry-based ligand binding assays in biomedical research., PMID:39964118

In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis., PMID:39742283

A novel method for recombinant mammalian-expressed S-HBsAg virus-like particle production for assembly status analysis and improved anti-HBs serology., PMID:39660966

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease., PMID:39591144

Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells., PMID:39474429

Coxiella burnetii Nine Mile phase I primary infection derived protective immunity against C. burnetii reinfection in mice depends on both B and T cells, but T cells play a critical role., PMID:39469719

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease., PMID:39468971

Targeting Cyclophilin A in the Cardiac Microenvironment Preserves Heart Function and Structure in Failing Hearts., PMID:39140165

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease., PMID:39066413

Nanobodies as novel tools to monitor the mitochondrial fission factor Drp1., PMID:38816213

Ultraviolet C inactivation of Coxiella burnetii for production of a structurally preserved whole cell vaccine antigen., PMID:38575865

Nature as blueprint: Global phenotype engineering of CHO production cells based on a multi-omics comparison with plasma cells., PMID:38561148

Development and validation of a respiratory syncytial virus multiplex immunoassay., PMID:38332255

Two birds with one stone: human SIRPα nanobodies for functional modulation and in vivo imaging of myeloid cells., PMID:38164132

SARS-CoV-2 specific sIgA in saliva increases after disease-related video stimulation., PMID:38123577

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults., PMID:38016500

Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel., PMID:38008353

30 years of nanobodies - an ongoing success story of small binders in biological research., PMID:37937477

Differential levels of anti-Mycobacterium tuberculosis-specific IgAs in saliva of household contacts with latent tuberculosis infection., PMID:37869168

Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia., PMID:37864073

Erratum: Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test., PMID:37585561

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease., PMID:37571863

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test., PMID:37522730

A Combined Western and Bead-Based Multiplex Platform to Characterize Extracellular Vesicles., PMID:37470213

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates., PMID:37376656

Aptamer-Based Electrochemical Microfluidic Biosensor for the Detection of Cryptosporidium parvum., PMID:37207303

[Not Available]., PMID:37073321

HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role., PMID:36835131

Transcription Factors STAT3 and MYC Are Key Players of Human Platelet Lysate-Induced Cell Proliferation., PMID:36555426

Plasma biomarkers TAP, CPA1, and CPA2 for the detection of pancreatic injury in rat: the development of a novel multiplex IA-LC-MS/MS assay and biomarker performance evaluation., PMID:36481916

Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations., PMID:36400804

Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies., PMID:36396985

PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer., PMID:36329884

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity., PMID:36301637

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients., PMID:36275672

Spatial Proteomics Reveals Differences in the Cellular Architecture of Antibody-Producing CHO and Plasma Cell-Derived Cells., PMID:35934186

Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19., PMID:35926164

Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants., PMID:35717657

The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia., PMID:35679071

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants., PMID:35505068

Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany., PMID:35251012

Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity., PMID:35028605

Human immunocompetent choroid-on-chip: a novel tool for studying ocular effects of biological drugs., PMID:35027657

Robust and durable serological response following pediatric SARS-CoV-2 infection., PMID:35013206

Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells., PMID:34956237

Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors., PMID:34928979

Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern., PMID:34927793

A multiplexed, automated immuno-matrix assisted laser desorption/ionization mass spectrometry assay for simultaneous and precise quantitation of PTEN and p110α in cell lines and tumor tissues., PMID:34585690

Nanobodies - Little helpers unravelling intracellular signaling., PMID:34536541

Datasheet

Document Download

Anti-NMI Antibody (R1B09).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-NMI Antibody (R1B09) [RHG47301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only